Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Mo-Rez shows 62% response rate in platinum-resistant ovarian cancer


RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer


Sofe-M combination shows 79% response rate in platinum-sensitive ovarian cancer


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Material Requirements to Support Gene Therapy Development

Presented by Clare Blue, Director of Analytical Development at Biogen and James Wilkinson, VP of Sales and Customer Success at Refeyn
19th May 2022


Implementing CMC Strategies for scale-up operations in biologics manufacturing

Presented by Dr Anita Krishnan, Assistant Director, Head, CMC development at Lupin and Dr. Annu Uppal Manager Biopharmaceutical Applications at AB SCIEX
05th October 2018


Changing the Paradigm: Moving to In-Process Release Testing

Presented by Presented by Scott Weiss, Director, Industrial Microbiology at Johnson & Johnson and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
05th February 2021


View All Past Webinars

Featured Companies

 

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

 

View All Videos

Technical Papers

Column Packing Protocol for Amsphere A3


Rationale Design of Valves for Flexible Processing


Strategy Emerging Markets for Risk Mitigation


Read All Technical Papers

Featured Products

Decrease Cleaning Validation Time and Resources


AdvantaPure


Amsphere™ A3 Protein A Resin – JSR Life Sciences


View All Products

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia